CCI Achieves 98% Compliance After FDA Re-Inspection
Cricket Club of India claims high compliance score, FDA to review report.

The Cricket Club of India (CCI) in Mumbai has announced that it has achieved a 98% compliance score in a re-inspection conducted by the Maharashtra Food and Drug Administration (FDA) on Monday. This development comes after the FDA suspended the club's food business licence due to serious food safety and hygiene violations.
The FDA had carried out a surprise inspection at the club on July 27, which revealed multiple violations of food safety norms. The inspection found critical lapses, including pest infestation, expired food, and unhygienic waste management. The club's licence was suspended pending corrective measures.
In a communication to members, the club stated that the re-inspection had been completed and that the club received a 98% compliance score. The final update regarding the club's status would be communicated to members by the end of Tuesday.
The initial inspection had highlighted several deficiencies, including the absence of segregation between vegetarian and non-vegetarian food preparation areas, heavy infestation of live cockroaches and flies, and unhygienic waste management. The inspection also found mouldy vegetables, overripe mushrooms, and expired food items in storage.
The FDA is yet to issue its final order on whether the suspension will be revoked and the licence restored. The final decision is expected after the department reviews the inspection report and verifies full compliance with food safety regulations.
The CCI has addressed most of the deficiencies identified by the regulator, according to the latest re-inspection. However, the FDA's final decision is still pending.
The suspension of the club's licence had raised concerns about food safety and hygiene at the prestigious club. The CCI is a popular destination for sports and social events in Mumbai, and the suspension had affected its operations.
The FDA's decision to suspend the club's licence was seen as a crackdown on food safety violations in the city. The regulator has been conducting regular inspections at food establishments to ensure compliance with food safety regulations.
The CCI's claim of achieving a 98% compliance score is a positive development, but the final decision on the suspension of its licence is still pending. The club's members and patrons will have to wait for the FDA's final order to know the status of the club's operations.
In the meantime, the CCI has assured its members that it is taking all necessary steps to ensure compliance with food safety regulations. The club's commitment to food safety and hygiene is a welcome step, and it is expected to maintain high standards in the future.
The FDA's efforts to ensure food safety and hygiene in Mumbai are commendable, and the regulator's decision to suspend the CCI's licence was a necessary step to address the serious violations found at the club. The final decision on the suspension will be eagerly awaited by the club's members and patrons.
The incident highlights the importance of food safety and hygiene in public establishments. It is essential for food establishments to maintain high standards of hygiene and safety to prevent foodborne illnesses. The FDA's efforts to ensure compliance with food safety regulations are crucial in maintaining public health and safety.
In conclusion, the CCI's claim of achieving a 98% compliance score is a positive development, but the final decision on the suspension of its licence is still pending. The FDA's efforts to ensure food safety and hygiene in Mumbai are commendable, and the regulator's decision to suspend the CCI's licence was a necessary step to address the serious violations found at the club.
Frequently asked questions
What was the reason for the FDA's suspension of the CCI's licence?
The FDA suspended the CCI's licence due to serious food safety and hygiene violations, including pest infestation, expired food, and unhygienic waste management.
What is the current status of the CCI's licence?
The CCI's licence is still suspended, pending the FDA's final decision on whether to revoke the suspension and restore the licence.